Cargando…

SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE

On the basis of progress of the Machine Learning algorithm mainly on the Deep Learning, improvement of the GPU performance, the large-scale public database such as TCGA is available, big attention recently gathers in the AI technology. While large countries such as the United States or China vigorou...

Descripción completa

Detalles Bibliográficos
Autor principal: Hamamoto, Ryuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213236/
http://dx.doi.org/10.1093/noajnl/vdz039.007
_version_ 1783531760317890560
author Hamamoto, Ryuji
author_facet Hamamoto, Ryuji
author_sort Hamamoto, Ryuji
collection PubMed
description On the basis of progress of the Machine Learning algorithm mainly on the Deep Learning, improvement of the GPU performance, the large-scale public database such as TCGA is available, big attention recently gathers in the AI technology. While large countries such as the United States or China vigorously promote AI research and development by a national policy, Cabinet Office, Government of Japan, also emphasized the importance of AI technologies in the 5(th) Science and Technology Basic Plan in 2016. As for the AI development, it is wrestled relatively for a long time; the word “Artificial Intelligence” was firstly used in the Dartmouth workshop in 1956. However, the AI development has not been promoted smoothly until now and repeats the active state period and the period of depression. As the current active state period of AI is called as the third AI boom, the most different point of this boom and the other booms is that AI technologies have already been involved in our social life such as the AI-based face authentication device in this period. Indeed, The US Food and Drug Administration (FDA) has already authorized around 30 AI-based medical instruments, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan also authorized the first AI-based medical instrument last year. Therefore, now is the important time that we need to consider deeply for the creation of an affluent society, which enables coexistence of human being and AI. In this lecture, I particularly focus on medical imaging analysis using AI technologies and, would like to lecture on an action to the medical care application of the AI technology based on the experience that promoted medical AI research as the leader of two national projects relevant to medical AI called CREST and PRISM, and RIKEN AIP center.
format Online
Article
Text
id pubmed-7213236
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72132362020-07-07 SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE Hamamoto, Ryuji Neurooncol Adv Abstracts On the basis of progress of the Machine Learning algorithm mainly on the Deep Learning, improvement of the GPU performance, the large-scale public database such as TCGA is available, big attention recently gathers in the AI technology. While large countries such as the United States or China vigorously promote AI research and development by a national policy, Cabinet Office, Government of Japan, also emphasized the importance of AI technologies in the 5(th) Science and Technology Basic Plan in 2016. As for the AI development, it is wrestled relatively for a long time; the word “Artificial Intelligence” was firstly used in the Dartmouth workshop in 1956. However, the AI development has not been promoted smoothly until now and repeats the active state period and the period of depression. As the current active state period of AI is called as the third AI boom, the most different point of this boom and the other booms is that AI technologies have already been involved in our social life such as the AI-based face authentication device in this period. Indeed, The US Food and Drug Administration (FDA) has already authorized around 30 AI-based medical instruments, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan also authorized the first AI-based medical instrument last year. Therefore, now is the important time that we need to consider deeply for the creation of an affluent society, which enables coexistence of human being and AI. In this lecture, I particularly focus on medical imaging analysis using AI technologies and, would like to lecture on an action to the medical care application of the AI technology based on the experience that promoted medical AI research as the leader of two national projects relevant to medical AI called CREST and PRISM, and RIKEN AIP center. Oxford University Press 2019-12-16 /pmc/articles/PMC7213236/ http://dx.doi.org/10.1093/noajnl/vdz039.007 Text en © The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Hamamoto, Ryuji
SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE
title SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE
title_full SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE
title_fullStr SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE
title_full_unstemmed SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE
title_short SS1-KL-1 APPLICATION OF AI TECHNOLOGIES FOR MEDICAL CARE
title_sort ss1-kl-1 application of ai technologies for medical care
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213236/
http://dx.doi.org/10.1093/noajnl/vdz039.007
work_keys_str_mv AT hamamotoryuji ss1kl1applicationofaitechnologiesformedicalcare